speb/financial-data huggingface dataset:
ABUS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -7330000.00
ABUS income_statement (quarterly, 2025-09-30) — Normalized Income: -7364000.00
ABUS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -5817000.00
ABUS income_statement (quarterly, 2025-09-30) — Operating Income: -8293000.00
ABUS income_statement (quarterly, 2025-09-30) — Operating Revenue: 529000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 191953665.00
ABUS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2835000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 763000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -48129000.00
ABUS income_statement (quarterly, 2025-09-30) — Other Gand A: 3044000.00
ABUS income_statement (quarterly, 2025-09-30) — Other Income Expense: -378000.00
ABUS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 42000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 131000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 14736000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Other Properties: 13484000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 71294000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Payables: 1011000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3890000.00
ABUS income_statement (quarterly, 2025-09-30) — Pretax Income: -7742000.00
ABUS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 844000.00
ABUS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -51300000.00
ABUS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Receivables: 905000.00
ABUS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 11000.00
ABUS income_statement (quarterly, 2025-09-30) — Research And Development: 5778000.00
ABUS income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 366000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1376317000.00
ABUS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 41281000.00
ABUS cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
ABUS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3044000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Share Issued: 191953665.00
ABUS income_statement (quarterly, 2025-09-30) — Special Income Charges: -366000.00
ABUS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1263000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 77399000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 77399000.00
ABUS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ABUS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Total Assets: 97710000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 77399000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Total Debt: 922000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 77399000.00
ABUS income_statement (quarterly, 2025-09-30) — Total Expenses: 8822000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 20311000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 268000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 15127000.00
ABUS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -8659000.00
ABUS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -378000.00
ABUS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -378000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Working Capital: 92258000.00
ABUS income_statement (annual, 2025-12-31) — +Operating Expense: 41134000.00
ABUS income_statement (quarterly, 2025-12-31) — +Operating Expense: 8695000.00
ABUS income_statement (annual, 2025-12-31) — +Total Revenue: 14083000.00
ABUS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1051000.00
ABUS balance_sheet (annual, 2025-12-31) — Accounts Payable: 1173000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1173000.00
ABUS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1447000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1447000.00
ABUS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -213000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -213000.00
ABUS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 83318000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 83318000.00
ABUS cash_flow (annual, 2025-12-31) — Amortization Of Securities: -2349000.00
ABUS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -422000.00
ABUS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2811000.00
ABUS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
ABUS income_statement (annual, 2025-12-31) — Basic Average Shares: 191599600.00
ABUS income_statement (annual, 2025-12-31) — Basic EPS: -0.17
ABUS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 36330000.00
ABUS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 22408000.00
ABUS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 746000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 746000.00
ABUS balance_sheet (annual, 2025-12-31) — Capital Stock: 1421429000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1421429000.00
ABUS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 18008000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 18008000.00
ABUS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 91471000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 91471000.00
ABUS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5721000.00
ABUS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1640000.00
ABUS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 15580000.00
ABUS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1361000.00
ABUS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -39637000.00
ABUS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4680000.00
ABUS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -557000.00
ABUS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -177000.00
ABUS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -10434000.00
ABUS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 0.00
ABUS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -2105000.00
ABUS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 806000.00
ABUS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1698000.00
ABUS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 1298000.00
ABUS cash_flow (annual, 2025-12-31) — Change In Receivables: 1375000.00
ABUS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -129000.00
ABUS cash_flow (annual, 2025-12-31) — Change In Working Capital: -10023000.00
ABUS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1798000.00
ABUS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1375000.00
ABUS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -129000.00
ABUS cash_flow (annual, 2025-12-31) — Changes In Cash: -18336000.00
ABUS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4401000.00
ABUS balance_sheet (annual, 2025-12-31) — Common Stock: 1421429000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Common Stock: 1421429000.00
ABUS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 76576000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 76576000.00
ABUS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
ABUS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 3646000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3646000.00
ABUS balance_sheet (annual, 2025-12-31) — Current Assets: 94456000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Current Assets: 94456000.00
ABUS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 547000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 547000.00
ABUS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 547000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 547000.00
ABUS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 0.00
ABUS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 0.00
ABUS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Current Liabilities: 6006000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 6006000.00
ABUS cash_flow (annual, 2025-12-31) — Depreciation: 363000.00
ABUS cash_flow (quarterly, 2025-12-31) — Depreciation: 11000.00
ABUS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 363000.00
ABUS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 11000.00
ABUS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 363000.00
ABUS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 11000.00
ABUS income_statement (annual, 2025-12-31) — Diluted Average Shares: 191599600.00
ABUS income_statement (annual, 2025-12-31) — Diluted EPS: -0.17
ABUS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3756000.00
ABUS income_statement (annual, 2025-12-31) — EBIT: -33404000.00
ABUS income_statement (quarterly, 2025-12-31) — EBIT: -3738000.00
ABUS income_statement (annual, 2025-12-31) — EBITDA: -33041000.00
ABUS income_statement (quarterly, 2025-12-31) — EBITDA: -3727000.00
ABUS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 14000.00
ABUS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 1000.00
ABUS cash_flow (annual, 2025-12-31) — End Cash Position: 18008000.00
ABUS cash_flow (quarterly, 2025-12-31) — End Cash Position: 18008000.00
ABUS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 5721000.00
ABUS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1640000.00
ABUS cash_flow (annual, 2025-12-31) — Free Cash Flow: -39637000.00
ABUS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4680000.00
ABUS cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -674000.00
ABUS income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 674000.00
ABUS income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 14000.00
ABUS income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1000.00
ABUS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -48098000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -48098000.00
ABUS income_statement (annual, 2025-12-31) — General And Administrative Expense: 15893000.00
ABUS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3689000.00
ABUS balance_sheet (annual, 2025-12-31) — Gross PPE: 245000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 245000.00
ABUS income_statement (annual, 2025-12-31) — Interest Expense: 97000.00
ABUS income_statement (quarterly, 2025-12-31) — Interest Expense: 18000.00
ABUS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 97000.00
ABUS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 18000.00
ABUS income_statement (annual, 2025-12-31) — Interest Income: 4068000.00
ABUS income_statement (quarterly, 2025-12-31) — Interest Income: 877000.00
ABUS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 4068000.00
ABUS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 877000.00
ABUS balance_sheet (annual, 2025-12-31) — Invested Capital: 76576000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 76576000.00
ABUS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 15580000.00
ABUS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1361000.00
ABUS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
ABUS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Leases: 0.00
ABUS balance_sheet (quarterly, 2025-12-31) — Leases: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 199000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 199000.00
ABUS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 199000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 199000.00
ABUS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 245000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 245000.00
ABUS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
ABUS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
ABUS income_statement (annual, 2025-12-31) — Net Income: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Income: -3756000.00
ABUS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3756000.00
ABUS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3756000.00
ABUS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3756000.00
ABUS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3756000.00
ABUS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -33501000.00
ABUS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3756000.00
ABUS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3756000.00
ABUS income_statement (annual, 2025-12-31) — Net Interest Income: 3971000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Interest Income: 859000.00
ABUS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 15216000.00
ABUS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1716000.00
ABUS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3971000.00
ABUS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 859000.00
ABUS balance_sheet (annual, 2025-12-31) — Net PPE: 32000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Net PPE: 32000.00
ABUS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 364000.00
ABUS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 355000.00
ABUS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 76576000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 76576000.00
ABUS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 0.00
ABUS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 0.00
ABUS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 0.00
ABUS income_statement (annual, 2025-12-31) — Normalized EBITDA: -22620000.00
ABUS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -6756000.00
ABUS income_statement (annual, 2025-12-31) — Normalized Income: -23080000.00
ABUS income_statement (quarterly, 2025-12-31) — Normalized Income: -6785000.00
ABUS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -39637000.00
ABUS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4680000.00
ABUS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -674000.00
ABUS income_statement (annual, 2025-12-31) — Operating Income: -27051000.00
ABUS income_statement (quarterly, 2025-12-31) — Operating Income: -7644000.00
ABUS income_statement (annual, 2025-12-31) — Operating Revenue: 14083000.00
ABUS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1051000.00
ABUS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 192531225.00
ABUS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 192531225.00
ABUS balance_sheet (annual, 2025-12-31) — Other Current Assets: 1538000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1538000.00
ABUS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 640000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 640000.00
ABUS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -48098000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -48098000.00
ABUS income_statement (annual, 2025-12-31) — Other Gand A: 15893000.00
ABUS income_statement (quarterly, 2025-12-31) — Other Gand A: 3689000.00
ABUS income_statement (annual, 2025-12-31) — Other Income Expense: -10421000.00
ABUS income_statement (quarterly, 2025-12-31) — Other Income Expense: 3029000.00
ABUS cash_flow (annual, 2025-12-31) — Other Non Cash Items: -3217000.00
ABUS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -2899000.00
ABUS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 130000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 130000.00
ABUS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 11837000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 11837000.00
ABUS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 73463000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 73463000.00
ABUS balance_sheet (annual, 2025-12-31) — Payables: 1173000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Payables: 1173000.00
ABUS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 4819000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4819000.00
ABUS income_statement (annual, 2025-12-31) — Pretax Income: -33501000.00
ABUS income_statement (quarterly, 2025-12-31) — Pretax Income: -3756000.00
ABUS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 5721000.00
ABUS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1640000.00
ABUS balance_sheet (annual, 2025-12-31) — Properties: 0.00
ABUS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ABUS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -140061000.00
ABUS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -25547000.00
ABUS cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
ABUS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Receivables: 1447000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Receivables: 1447000.00
ABUS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 363000.00
ABUS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 11000.00
ABUS income_statement (annual, 2025-12-31) — Research And Development: 25241000.00
ABUS income_statement (quarterly, 2025-12-31) — Research And Development: 5006000.00
ABUS income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 11109000.00
ABUS income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: -2354000.00
ABUS balance_sheet (annual, 2025-12-31) — Retained Earnings: -1380073000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1380073000.00
ABUS cash_flow (annual, 2025-12-31) — Sale Of Investment: 155277000.00
ABUS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 23831000.00
ABUS cash_flow (annual, 2025-12-31) — Sale Of PPE: 364000.00
ABUS cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 355000.00
ABUS income_statement (annual, 2025-12-31) — Selling General And Administration: 15893000.00
ABUS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3689000.00
ABUS balance_sheet (annual, 2025-12-31) — Share Issued: 192531225.00
ABUS balance_sheet (quarterly, 2025-12-31) — Share Issued: 192531225.00
ABUS income_statement (annual, 2025-12-31) — Special Income Charges: -10435000.00
ABUS income_statement (quarterly, 2025-12-31) — Special Income Charges: 3028000.00
ABUS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 6953000.00
ABUS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1262000.00
ABUS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 76576000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 76576000.00
ABUS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 76576000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 76576000.00
ABUS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ABUS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ABUS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
ABUS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ABUS balance_sheet (annual, 2025-12-31) — Total Assets: 94618000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Total Assets: 94618000.00
ABUS balance_sheet (annual, 2025-12-31) — Total Capitalization: 76576000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 76576000.00
ABUS balance_sheet (annual, 2025-12-31) — Total Debt: 746000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Total Debt: 746000.00
ABUS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 76576000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 76576000.00
ABUS income_statement (annual, 2025-12-31) — Total Expenses: 41134000.00
ABUS income_statement (quarterly, 2025-12-31) — Total Expenses: 8695000.00
ABUS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 18042000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 18042000.00
ABUS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 162000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 162000.00
ABUS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 12036000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 12036000.00
ABUS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -38160000.00
ABUS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -5290000.00
ABUS income_statement (annual, 2025-12-31) — Total Unusual Items: -10421000.00
ABUS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 3029000.00
ABUS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10421000.00
ABUS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 3029000.00
ABUS balance_sheet (annual, 2025-12-31) — Working Capital: 88450000.00
ABUS balance_sheet (quarterly, 2025-12-31) — Working Capital: 88450000.00
ABUS income_statement (quarterly, 2026-03-31) — +Operating Expense: 10009000.00
ABUS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1881061.89
ABUS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1462000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1312000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -224000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 74256000.00
ABUS cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -354000.00
ABUS cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
ABUS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 193768641.00
ABUS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.88
ABUS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 18008000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 631000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1444494000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 23706000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 95226000.00
ABUS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 11619000.00
ABUS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 2200000.00
ABUS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -8110000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -985000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -105000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -178741000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Payable: -985000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -985000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -195000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1160000.00
ABUS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -178866000.00
ABUS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 1160000.00
ABUS cash_flow (quarterly, 2026-03-31) — Changes In Cash: 5708000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1444494000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 260177000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2767000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Current Assets: 277011000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 631000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 631000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5105000.00
ABUS cash_flow (quarterly, 2026-03-31) — Depreciation: 11000.00
ABUS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 11000.00
ABUS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 11000.00
ABUS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 195214067.00
ABUS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.87
ABUS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 169695000.00
ABUS income_statement (quarterly, 2026-03-31) — EBIT: 169712000.00
ABUS income_statement (quarterly, 2026-03-31) — EBITDA: 169723000.00
ABUS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -10000.00
ABUS cash_flow (quarterly, 2026-03-31) — End Cash Position: 23706000.00
ABUS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 11619000.00
ABUS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -8110000.00
ABUS income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -11000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -48195000.00
ABUS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5889000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 246000.00
ABUS income_statement (quarterly, 2026-03-31) — Interest Expense: 17000.00
ABUS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 17000.00
ABUS income_statement (quarterly, 2026-03-31) — Interest Income: 815000.00
ABUS income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 815000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 260177000.00
ABUS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 2199000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 0.00
ABUS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
ABUS income_statement (quarterly, 2026-03-31) — Net Income: 169695000.00
ABUS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 169695000.00
ABUS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 169695000.00
ABUS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 169695000.00
ABUS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 169695000.00
ABUS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 169695000.00
ABUS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 169695000.00
ABUS income_statement (quarterly, 2026-03-31) — Net Interest Income: 798000.00
ABUS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 2200000.00
ABUS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 798000.00
ABUS cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -1000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Net PPE: 22000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 260177000.00
ABUS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 169943000.00
ABUS income_statement (quarterly, 2026-03-31) — Normalized Income: 169827000.00
ABUS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -8110000.00
ABUS income_statement (quarterly, 2026-03-31) — Operating Income: 169117000.00
ABUS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1881061.89
ABUS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 196947757.00
ABUS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1732000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 245000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -48195000.00
ABUS income_statement (quarterly, 2026-03-31) — Other Gand A: 5889000.00
ABUS income_statement (quarterly, 2026-03-31) — Other Income Expense: -220000.00
ABUS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 45000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 131000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 11882000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 178741000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 71520000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Payables: 1462000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4229000.00
ABUS income_statement (quarterly, 2026-03-31) — Pretax Income: 169695000.00
ABUS cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 11619000.00
ABUS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -13800000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Receivables: 180053000.00
ABUS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 11000.00
ABUS income_statement (quarterly, 2026-03-31) — Research And Development: 4120000.00
ABUS income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 209000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1210378000.00
ABUS cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 16000000.00
ABUS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5889000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Share Issued: 196947757.00
ABUS income_statement (quarterly, 2026-03-31) — Special Income Charges: -209000.00
ABUS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1359000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 260177000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 260177000.00
ABUS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -88000.00
ABUS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ABUS balance_sheet (quarterly, 2026-03-31) — Total Assets: 277164000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 260177000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Total Debt: 631000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 260177000.00
ABUS income_statement (quarterly, 2026-03-31) — Total Expenses: 10009000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 16987000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 153000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 11882000.00
ABUS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 168908000.00
ABUS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -220000.00
ABUS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -220000.00
ABUS balance_sheet (quarterly, 2026-03-31) — Working Capital: 271906000.00
ABV.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 379148766.00
ABV.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 406000.00
ABV.AX balance_sheet (annual, 2021-06-30) — Cash Equivalents: 42000.00
ABV.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 379148766.00
ABV.AX balance_sheet (annual, 2021-06-30) — Finished Goods: 1886000.00
ABV.AX income_statement (annual, 2021-06-30) — Gain On Sale Of Ppe: -1000.00
ABV.AX balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 406000.00
ABV.AX balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 406000.00
ABV.AX balance_sheet (annual, 2021-06-30) — Long Term Provisions: 18000.00
ABV.AX balance_sheet (annual, 2021-06-30) — Other Properties: 502000.00
ABV.AX balance_sheet (annual, 2021-06-30) — Receivables Adjustments Allowances: -20000.00
ABV.AX income_statement (annual, 2021-06-30) — Special Income Charges: -1000.00
ABV.AX income_statement (annual, 2021-06-30) — Total Unusual Items: -1000.00
ABV.AX income_statement (annual, 2021-06-30) — Total Unusual Items Excluding Goodwill: -1000.00
ABV.AX income_statement (annual, 2022-06-30) — +Operating Expense: 4728000.00
ABV.AX income_statement (annual, 2022-06-30) — +Total Revenue: 11088000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 1448000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 2033000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -734000.00
ABV.AX income_statement (annual, 2022-06-30) — Amortization: 64000.00
ABV.AX income_statement (annual, 2022-06-30) — Amortization Of Intangibles Income Statement: 64000.00
ABV.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 379149000.00
ABV.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.00
ABV.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 1411000.00
ABV.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -54000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 55819000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 1739000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 1739000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 1739000.00
ABV.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -42000.00
ABV.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -28000.00
ABV.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: 398000.00
ABV.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 328000.00
ABV.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -11413000.00
ABV.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 11818000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Common Stock: 55819000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 5325000.00
ABV.AX income_statement (annual, 2022-06-30) — Cost Of Revenue: 6284000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Current Assets: 9363000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Current Debt: 191000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 191000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 2327000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 110000.00
ABV.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 267000.00
ABV.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 267000.00
ABV.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 203000.00
ABV.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 402500000.00
ABV.AX income_statement (annual, 2022-06-30) — Diluted EPS: 0.00
ABV.AX income_statement (annual, 2022-06-30) — EBIT: 729000.00
ABV.AX income_statement (annual, 2022-06-30) — EBITDA: 996000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Employee Benefits: 6000.00
ABV.AX cash_flow (annual, 2022-06-30) — End Cash Position: 1739000.00
ABV.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: -42000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Finished Goods: 2318000.00
ABV.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: 344000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 237000.00
ABV.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 3074000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 543000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 1117000.00
ABV.AX income_statement (annual, 2022-06-30) — Gross Profit: 4804000.00
ABV.AX income_statement (annual, 2022-06-30) — Interest Expense: 85000.00
ABV.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 85000.00
ABV.AX income_statement (annual, 2022-06-30) — Interest Income: 4000.00
ABV.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 4000.00
ABV.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -10000.00
ABV.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 10000.00
ABV.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 4000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Inventories Adjustments Allowances: -74000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Inventory: 2244000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 5516000.00
ABV.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -28000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Leases: 97000.00
ABV.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -42000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 1020000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Income: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Interest Income: -81000.00
ABV.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -42000.00
ABV.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -42000.00
ABV.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -81000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Net PPE: 383000.00
ABV.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -28000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 4782000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 6000.00
ABV.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: 996000.00
ABV.AX income_statement (annual, 2022-06-30) — Normalized Income: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Operating Income: 76000.00
ABV.AX income_statement (annual, 2022-06-30) — Operating Revenue: 11088000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 379148766.00
ABV.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: 654000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 443000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Other Current Borrowings: 191000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 237000.00
ABV.AX income_statement (annual, 2022-06-30) — Other Gand A: 32000.00
ABV.AX income_statement (annual, 2022-06-30) — Other Income Expense: 649000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 543000.00
ABV.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 649000.00
ABV.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 1310000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Other Payable: 403000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Payables: 1851000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 1851000.00
ABV.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -11413000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 175000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 313000.00
ABV.AX income_statement (annual, 2022-06-30) — Pretax Income: 644000.00
ABV.AX income_statement (annual, 2022-06-30) — Provision For Doubtful Accounts: 20000.00
ABV.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -54000.00
ABV.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 11164000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Receivables: 1993000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Receivables Adjustments Allowances: -40000.00
ABV.AX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 6284000.00
ABV.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 267000.00
ABV.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -42000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -50731000.00
ABV.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 3042000.00
ABV.AX cash_flow (annual, 2022-06-30) — Sale Of PPE: 26000.00
ABV.AX income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 57000.00
ABV.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 3131000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Share Issued: 379148766.00
ABV.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 5325000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 4782000.00
ABV.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
ABV.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
ABV.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
ABV.AX cash_flow (annual, 2022-06-30) — Taxes Refund Paid Direct: -1000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Total Assets: 7658000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 5325000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Total Debt: 191000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 5325000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 2339000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 926000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 12000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Work In Process: 2318000.00
ABV.AX balance_sheet (annual, 2022-06-30) — Working Capital: 7036000.00
ABV.AX income_statement (annual, 2023-06-30) — +Operating Expense: 6047000.00
ABV.AX income_statement (annual, 2023-06-30) — +Total Revenue: 14150000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 1830000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 1959000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -1181000.00
ABV.AX income_statement (annual, 2023-06-30) — Amortization: 64000.00
ABV.AX income_statement (annual, 2023-06-30) — Amortization Of Intangibles Income Statement: 64000.00
ABV.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 379261000.00
ABV.AX income_statement (annual, 2023-06-30) — Basic EPS: 0.00
ABV.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 1739000.00
ABV.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -665000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 1157000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 55833000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 2048000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 2048000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 2048000.00
ABV.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: -6000.00
ABV.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -665000.00
ABV.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: 980000.00
ABV.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 309000.00
ABV.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -14667000.00
ABV.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 15622000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Common Stock: 55833000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 6947000.00
ABV.AX income_statement (annual, 2023-06-30) — Cost Of Revenue: 7099000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Current Assets: 8469000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 41000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Current Debt: 223000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 264000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 2862000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 141000.00
ABV.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 259000.00
ABV.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 259000.00
ABV.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 195000.00
ABV.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 409444444.00
ABV.AX income_statement (annual, 2023-06-30) — Diluted EPS: 0.00
ABV.AX income_statement (annual, 2023-06-30) — EBIT: 1544000.00
ABV.AX income_statement (annual, 2023-06-30) — EBITDA: 1803000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Employee Benefits: 9000.00
ABV.AX cash_flow (annual, 2023-06-30) — End Cash Position: 2048000.00
ABV.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: -6000.00
ABV.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: 315000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 371000.00
ABV.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 3655000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 480000.00
ABV.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 3191000.00